• Multiple class action lawsuits allege material data security and privacy failures at Hims & Hers Health, including delayed notification to affected customers.
• The cases focus on how NYSE:HIMS handled alleged data breaches tied to its digital health platforms.
• The lawsuits introduce new legal and reputational questions that were not central in earlier discussions of the company.

Hims & Hers Health, traded as NYSE:HIMS, sits at the intersection of consumer brands and telehealth, with a current share price of $27.17. The stock has been volatile, with a 30.9% return over the past 30 days and a 131.6% return over 3 years, alongside a 24.9% decline over the past year. These swings reflect changing views on the company’s growth prospects and risk profile as it builds out its digital health offerings.

The new class action lawsuits add another layer of uncertainty, particularly around data security, customer trust, and potential legal costs. As Hims & Hers expands into more geographies and services, readers may want to watch how management addresses these privacy questions, any regulatory responses, and whether the company makes visible changes to its security and disclosure practices.

Stay updated on the most important news stories for Hims & Hers Health by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Hims & Hers Health.

Quick Assessment

• ⚖️ Price vs Analyst Target: At US$27.17, Hims & Hers Health trades about 3.5% above the US$26.25 analyst price target, which sits inside a US$18 to US$35 range.
• ✅ Simply Wall St Valuation: Shares are flagged as undervalued, trading about 55.6% below Simply Wall St's DCF based fair value estimate.
• ✅ Recent Momentum: The stock has returned roughly 30.9% over the past 30 days, showing strong short term momentum despite the legal headlines.

There is only one way to know the right time to buy, sell or hold Hims & Hers Health: head to Simply Wall St's company report for the latest analysis of Hims & Hers Health's Fair Value.

Key Considerations

• 📊 The data security lawsuits go straight to trust in Hims & Hers Health's digital platform, which is central to its business model.
• 📊 Keep an eye on any disclosed legal provisions, regulatory findings, and whether management outlines clearer data protection and disclosure policies.
• ⚠️ The most direct risk is unexpected legal or compliance costs combined with already high share price volatility flagged in the risk summary.

Dig Deeper

For the full picture, including more risks and rewards, check out the complete Hims & Hers Health analysis. Alternatively, you can visit the community page for Hims & Hers Health to see how other investors believe this latest news will impact the company's narrative.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.